Cytokinetics Publicizes Sanofi Acquired Rights to Develop and Commercialize Aficamten in Better China By Investing.com
SOUTH SAN FRANCISCO, Calif., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Cytokinetics (NASDAQ:),…
Sanofi enters unique talks with CD&R for Opella sale By Reuters
PARIS (Reuters) -Sanofi stated on Monday it had entered unique talks for…
Sanofi to promote 51% stake in Opella to CD&R, 1% to BPI By Reuters
PARIS (Reuters) - France will take a stake in Sanofi (NASDAQ:)'s Opella…
